Literature DB >> 1939015

Secretory expression of the human serum albumin gene in the yeast, Saccharomyces cerevisiae.

K Okabayashi1, Y Nakagawa, N Hayasuke, H Ohi, M Miura, Y Ishida, M Shimizu, K Murakami, K Hirabayashi, H Minamino.   

Abstract

We have fused a cDNA gene encoding mature human serum albumin (HSA) to several secretory leader-encoding sequences. The hybrid genes were cloned into an episomal vector under the control of several yeast promoters and then introduced into yeast cells. The GAL1 promoter in combination with either the native HSA pre-sequence or a modified HSA pre-sequence gave the highest production of immunoreactive HSA, 90 mg/liter being reached in a shake flask culture. The invertase pre-sequence, the mating factor alpha 1 prepro-sequence, and the modified HSA pre-sequence directed accurate processing. In contrast, the chicken lysozyme pre-sequence and the native HSA pre-sequence directed incorrect processing. Episomal vectors were unstable within the host cells under non-selective culture conditions. To improve the plasmid stability, the hybrid genes were incorporated into an integrative vector. Transformants carrying multicopies of the plasmid integrated at the LEU2 locus stably secreted HSA. The highest yield of 65 mg/liter in a shake flask culture was obtained with the combination of the yeast glyceraldehyde-3-phosphate dehydrogenase promoter and the modified HSA pre-sequence. By constructing transformed strains containing multicopies of plasmids integrated at both the chromosome LEU2 and HIS4 loci, we have obtained a stable strain that continuously secretes as much as 85 mg HSA per liter of culture medium.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1939015     DOI: 10.1093/oxfordjournals.jbchem.a123527

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  3 in total

1.  Use of the KlADH4 promoter for ethanol-dependent production of recombinant human serum albumin in Kluyveromyces lactis.

Authors:  M Saliola; C Mazzoni; N Solimando; A Crisà; C Falcone; G Jung; R Fleer
Journal:  Appl Environ Microbiol       Date:  1999-01       Impact factor: 4.792

2.  Effects of neocarzinostatin-chimeric Fab conjugates on the growth of human pancreatic carcinoma xenografts.

Authors:  E Otsuji; T Yamaguchi; H Tsuruta; Y Yata; H Nishi; K Okamoto; K Taniguchi; M Kato; T Kotani; K Kitamura; T Takahashi
Journal:  Br J Cancer       Date:  1996-05       Impact factor: 7.640

3.  Biodistribution of neocarzinostatin conjugated to chimeric Fab fragments of the monoclonal antibody A7 in nude mice bearing human pancreatic cancer xenografts.

Authors:  E Otsuji; T Yamaguchi; N Yamaoka; K Taniguchi; M Kato; T Kotani; K Kitamura; T Takahashi
Journal:  Jpn J Cancer Res       Date:  1994-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.